Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

198 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real life picture of the use of intravenous immunoglobulins in idiopathic inflammatory myopathies: Results of a multicentric study.
Barsotti S, Cavazzana I, Zanframundo G, Neri R, Taraborelli M, Cioffi E, Cardelli C, Tripoli A, Codullo V, Tincani A, Cavagna L, Franceschini F, Mosca M. Barsotti S, et al. Among authors: cavagna l. Autoimmun Rev. 2021 Mar;20(3):102757. doi: 10.1016/j.autrev.2021.102757. Epub 2021 Jan 18. Autoimmun Rev. 2021. PMID: 33476815 Review.
Serologic profile and mortality rates of scleroderma renal crisis in Italy.
Codullo V, Cavazzana I, Bonino C, Alpini C, Cavagna L, Cozzi F, Del Papa N, Franceschini F, Guiducci S, Morozzi G, Ruffatti A, Ferri C, Giacomelli R, Matucci-Cerinic M, Valentini G, Montecucco C. Codullo V, et al. Among authors: cavagna l. J Rheumatol. 2009 Jul;36(7):1464-9. doi: 10.3899/jrheum.080806. Epub 2009 Jun 1. J Rheumatol. 2009. PMID: 19487262
Long-term safety of abatacept in patients with rheumatoid arthritis.
Atzeni F, Sarzi-Puttini P, Mutti A, Bugatti S, Cavagna L, Caporali R. Atzeni F, et al. Among authors: cavagna l. Autoimmun Rev. 2013 Oct;12(12):1115-7. doi: 10.1016/j.autrev.2013.06.011. Epub 2013 Jun 22. Autoimmun Rev. 2013. PMID: 23800448 Review.
WITHDRAWN: Abatacept as a first-line biological therapy.
Caporali R, Bugatti S, Cavagna L, Antivalle M, Atzeni F, Puttini PS. Caporali R, et al. Among authors: cavagna l. Autoimmun Rev. 2013 Jun 24:S1568-9972(13)00114-6. doi: 10.1016/j.autrev.2013.06.010. Online ahead of print. Autoimmun Rev. 2013. PMID: 23806564
Multi-antibody composition in lupus nephritis: isotype and antigen specificity make the difference.
Bonanni A, Vaglio A, Bruschi M, Sinico RA, Cavagna L, Moroni G, Franceschini F, Allegri L, Pratesi F, Migliorini P, Candiano G, Pesce G, Ravelli A, Puppo F, Martini A, Tincani A, Ghiggeri GM. Bonanni A, et al. Among authors: cavagna l. Autoimmun Rev. 2015 Aug;14(8):692-702. doi: 10.1016/j.autrev.2015.04.004. Epub 2015 Apr 14. Autoimmun Rev. 2015. PMID: 25888464 Review.
Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study.
Cavagna L, Nuño L, Scirè CA, Govoni M, Longo FJL, Franceschini F, Neri R, Castañeda S, Giraldo WAS, Caporali R, Iannone F, Fusaro E, Paolazzi G, Pellerito R, Schwarting A, Saketkoo LA, Ortego-Centeno N, Quartuccio L, Bartoloni E, Specker C, Murcia TP, La Corte R, Furini F, Foschi V, Corral JB, Airò P, Cavazzana I, Martínez-Barrio J, Hinojosa M, Giannini M, Barsotti S, Menke J, Triantafyllias K, Vitetta R, Russo A, Bajocchi G, Bravi E, Barausse G, Bortolotti R, Selmi C, Parisi S, Montecucco C, González-Gay MA; AENEAS (American, European NEtwork of Antisynthetase Syndrome) collaborative group.. Cavagna L, et al. Medicine (Baltimore). 2015 Aug;94(32):e1144. doi: 10.1097/MD.0000000000001144. Medicine (Baltimore). 2015. PMID: 26266346 Free PMC article.
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group.
Cavagna L, Nuño L, Scirè CA, Govoni M, Longo FJ, Franceschini F, Neri R, Castañeda S, Sifuentes Giraldo WA, Caporali R, Iannone F, Fusaro E, Paolazzi G, Pellerito R, Schwarting A, Saketkoo LA, Ortego-Centeno N, Quartuccio L, Bartoloni E, Specker C, Pina Murcia T, La Corte R, Furini F, Foschi V, Bachiller Corral J, Airò P, Cavazzana I, Martínez-Barrio J, Hinojosa M, Giannini M, Barsotti S, Menke J, Triantafyllias K, Vitetta R, Russo A, Bogliolo L, Bajocchi G, Bravi E, Barausse G, Bortolotti R, Selmi C, Parisi S, Salaffi F, Montecucco C, González-Gay MA; AENEAS (American and European NEtwork of Antisynthetase Syndrome) Collaborative Group. Cavagna L, et al. Clin Rev Allergy Immunol. 2017 Feb;52(1):71-80. doi: 10.1007/s12016-016-8528-9. Clin Rev Allergy Immunol. 2017. PMID: 26782036 Review.
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study.
Bartoloni E, Gonzalez-Gay MA, Scirè C, Castaneda S, Gerli R, Lopez-Longo FJ, Martinez-Barrio J, Govoni M, Furini F, Pina T, Iannone F, Giannini M, Nuño L, Quartuccio L, Ortego-Centeno N, Alunno A, Specker C, Montecucco C, Triantafyllias K, Balduzzi S, Sifuentes-Giraldo WA, Paolazzi G, Bravi E, Schwarting A, Pellerito R, Russo A, Selmi C, Saketkoo LA, Fusaro E, Parisi S, Pipitone N, Franceschini F, Cavazzana I, Neri R, Barsotti S, Codullo V, Cavagna L. Bartoloni E, et al. Among authors: cavagna l. Autoimmun Rev. 2017 Mar;16(3):253-257. doi: 10.1016/j.autrev.2017.01.008. Epub 2017 Jan 29. Autoimmun Rev. 2017. PMID: 28147261 Review.
198 results